FARRELL MICHAEL J. (Chief Executive Officer) sold 1.1% of their position (4.99K shares) of RESMED INC on the open market
Open‑market sale worth $1.25M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/11/2026ACC: 0000943819-26-000016
Officer· Chief Executive Officer
Since Aug 2018
-4.99K
Net shares
Net seller
$1.25M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.99K acquired · 9.98K disposed
Non-Derivative Transactions2
ResMed Common Stock
Direct
Shares
+4.99K
Price / share
$146.34
Trade value
$730.38K
% of position
1.1%
3/9/2026
466.22K→471.21K
ResMed Common Stock
Direct
Shares
−4.99K
Price / share
$251.03
Trade value
$1.25M
% of position
1.1%
3/9/2026
471.21K→466.22K
Total
Net shares
+0.00
Net value
-$522.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Direct | 3/9/2026 | M · Option Exercise | +4.99K | $146.34 | $730.38K | 1.1% | 466.22K | 471.21K |
| ResMed Common Stock Direct | 3/9/2026 | S · Sale | −4.99K | $251.03 | $1.25M | 1.1% | 471.21K | 466.22K |
| Total | +0.00 | -$522.52K | ||||||
Derivative Transactions1
ResMed Common Stock Options
Direct
Converts to
ResMed Common Stock
4.99K shares
Shares
−4.99K
Strike price
146.34
Held after
39.93K
Exercisable
—
3/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| ResMed Common Stock Options Direct | ResMed Common Stock4.99K shares | 3/9/2026 | M · Option Exercise | −4.99K | 146.34 | — | 39.93K |
Non-Derivative Holdings (Post-Transaction)1
ResMed Common Stock
IndirectShares owned2.09K
Total
2.09K indirect2.09K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| ResMed Common Stock | 2.09K | Indirect |
| Total | 2.09K | 2.09K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported